Role of Mutant p53 in the Progression of Chronic Lymphocytic Leukemia

被引：1
|
作者：
Ravikrishnan, Janani [1 ]
Lai, Tzung-Huei [1 ]
Muhowski, Elizabeth [1 ]
Brinton, Lindsey [1 ]
Williams, Katie [1 ]
Thompson, Alexandria [1 ]
Blachly, James S. [1 ,2 ]
Ozer, Hatice Gulcin [2 ]
Byrd, John C. [1 ]
Lapalombella, Rosa [1 ]
Woyach, Jennifer [1 ]
Sampath, Deepa [3 ]
机构：
[1] Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA
[3] Ohio State Univ, Div Hematol, Dept Internal Med, Wexner Med Ctr, Columbus, OH 43210 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-128574
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2526
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Targeting p53 in chronic lymphocytic leukemia
    Moia, Riccardo
    Boggione, Paola
    Mahmoud, Abdurraouf Mokhtar
    Kodipad, Ahad Ahmed
    Adhinaveni, Ramesh
    Sagiraju, Sruthi
    Patriarca, Andrea
    Gaidano, Gianluca
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (12) : 1239 - 1250
  • [2] p53 protein expression in chronic lymphocytic leukemia
    Sellmann, Ludger
    Carpinteiro, Alexander
    Nueckel, Holger
    Scholtysik, Rene
    Siemer, Doerte
    Klein-Hipass, Ludger
    Kube, Dieter
    Duerig, Jan
    Duehrsen, Ulrich
    Stanelle, Jens
    Kueppers, Ralf
    LEUKEMIA & LYMPHOMA, 2012, 53 (07) : 1282 - 1288
  • [3] Functional assessment of p53 in chronic lymphocytic leukemia
    Le Garff-Tavernier, M.
    Blons, H.
    Nguyen-Khac, F.
    Pannetier, M.
    Brissard, M.
    Gueguen, S.
    Jacob, F.
    Ysebaert, L.
    Susin, S. A.
    Merle-Beral, H.
    BLOOD CANCER JOURNAL, 2011, 1 : e5 - e5
  • [4] Functional assessment of p53 in chronic lymphocytic leukemia
    M Le Garff-Tavernier
    H Blons
    F Nguyen-Khac
    M Pannetier
    M Brissard
    S Gueguen
    F Jacob
    L Ysebaert
    S A Susin
    H Merle-Béral
    Blood Cancer Journal, 2011, 1 : e5 - e5
  • [5] Chronic lymphocytic leukemia and treatment resistance in cancer The role of the p53 pathway
    Zenz, Thorsten
    Benner, Axel
    Doehner, Hartmut
    Stilgenbauer, Stephan
    CELL CYCLE, 2008, 7 (24) : 3810 - 3814
  • [6] Treatment resistance in chronic lymphocytic leukemia-the role of the p53 pathway
    Zenz, Thorsten
    Mohr, Julia
    Edelmann, Jennifer
    Sarno, Antonio
    Hoth, Patrick
    Heuberger, Maria
    Helfrich, Hanne
    Mertens, Daniel
    Doehner, Hartmut
    Stilgenbauer, Stephan
    LEUKEMIA & LYMPHOMA, 2009, 50 (03) : 510 - 513
  • [7] Effect of Polymorphisms in p53 Pathway Proteins and B-Chronic Lymphocytic Leukemia Disease Progression
    Lee, Hyunjoo
    Liew, Anthony
    Lee, Annette
    Haque, Shabirul
    Kolitz, Jonathan E.
    Allen, Steven L.
    Rai, Kanti R.
    Gregersen, Peter
    Chu, Charles C.
    Chiorazzi, Nicholas
    Mongini, Patricia
    BLOOD, 2011, 118 (21) : 1661 - 1662
  • [8] Alemtuzumab for chronic lymphocytic leukemia with and without p53 deletions.
    Osuji, N
    Del Giudice, I
    Matutes, E
    Dearden, C
    Catovsky, D
    BLOOD, 2004, 104 (11) : 688A - 688A
  • [9] THE PROGNOSTIC EFFECT OF GENES IN THE P53 PATHWAY IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Oztan, Gozde
    Palanduz, Sukru
    Cefle, Kivanc
    NOBEL MEDICUS, 2018, 14 (02): : 5 - 16
  • [10] Targeting chronic lymphocytic leukemia with p53 deficiency with phenethyl isothiocyanate
    Liu, Jinyun
    Chen, Gang
    Pelicano, Helen
    CANCER RESEARCH, 2015, 75
12345